We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,295 hedge funds and large institutions have $45.6B invested in Edwards Lifesciences in 2024 Q2 according to their latest regulatory filings, with 122 funds opening new positions, 463 increasing their positions, 465 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 122 | Existing positions closed: 90

7% more funds holding in top 10

Funds holding in top 10: 14 → 15 (+1)

1% more funds holding

Funds holding: 1,279 → 1,295 (+16)

0.67% more ownership

Funds ownership: 81.25% → 81.93% (+0.67%)

0% less repeat investments, than reductions

Existing positions increased: 463 | Existing positions reduced: 465

2% less capital invested

Capital invested by funds: $46.6B → $45.6B (-$1.03B)

7% less call options, than puts

Call options by funds: $276M | Put options by funds: $297M

Holders
1,295
Holders Change
+16
Holders Change %
+1.25%
% of All Funds
18.7%
Holding in Top 10
15
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.14%
% of All Funds
0.22%
New
122
Increased
463
Reduced
465
Closed
90
Calls
$276M
Puts
$297M
Net Calls
-$21M
Net Calls Change
-$59.1M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$348M
2
SFFS
Stonehage Fleming Financial Services
Jersey
+$204M
3
UBS AM
UBS AM
Illinois
+$137M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$122M
5
Swedbank
Swedbank
Sweden
+$109M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$224M
2
Citadel Advisors
Citadel Advisors
Florida
-$179M
3
BlackRock
BlackRock
New York
-$128M
4
JP Morgan Chase
JP Morgan Chase
New York
-$81.7M
5
State Street
State Street
Massachusetts
-$67.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
DADC
451
D.A. Davidson & Co
Montana
$2.5M – – –
BWP
452
Baldwin Wealth Partners
Massachusetts
$2.49M -$62.7K -708 -3%
EOJOAM
453
E. Ohman J:or Asset Management
Sweden
$2.47M +$151K +1,700 +7%
FWP
454
FAS Wealth Partners
Kansas
$2.46M +$143K +1,613 +6%
CCM
455
Cox Capital Management
Massachusetts
$2.44M +$2.34M +26,443 New
DT
456
Diversified Trust
Tennessee
$2.4M -$190K -2,148 -8%
RIM
457
Rakuten Investment Management
Japan
$2.39M +$826K +9,330 +57%
EAM
458
EFG Asset Management
Oregon
$2.36M -$89.2K -1,007 -4%
Carson Wealth (CWM LLC)
459
Carson Wealth (CWM LLC)
Nebraska
$2.36M -$266 -3 -0%
SM
460
Sciencast Management
New Jersey
$2.35M +$2.26M +25,483 New
VIM
461
Vinva Investment Management
Australia
$2.35M +$125K +1,417 +6%
MCA
462
Martin Capital Advisors
Texas
$2.34M -$11.5K -130 -0.5%
SCA
463
Stonebridge Capital Advisors
Minnesota
$2.34M +$33.1K +374 +1%
BRCM
464
Bright Rock Capital Management
Massachusetts
$2.31M – – –
BS
465
Banco Santander
Spain
$2.29M -$65.4K -739 -3%
HIP
466
Harrell Investment Partners
Texas
$2.29M -$7.35K -83 -0.3%
CL
467
Choreo LLC
Illinois
$2.26M +$1.87M +21,137 +550%
SLI
468
Sumitomo Life Insurance
Japan
$2.24M +$25.2K +285 +1%
LA
469
LBP AM
France
$2.23M -$6.55K -74 -0.3%
SN
470
Sittner & Nelson
Oregon
$2.22M -$53.1K -600 -2%
IC
471
Inscription Capital
Texas
$2.22M – – –
DAS
472
Diversify Advisory Services
Utah
$2.2M -$552K -6,234 -21%
UB
473
Umpqua Bank
Oregon
$2.2M +$129K +1,461 +7%
Verition Fund Management
474
Verition Fund Management
Connecticut
$2.19M +$555K +6,267 +36%
PF
475
Phoenix Financial
Israel
$2.19M +$1.85M +20,930 +748%
17 18
19
20 21

EW Hedge Fund Activity: Q2 2024 in Review

1,295 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2024, worth a combined $45.6B — down 2.2% from $46.6B a quarter earlier.

Buyers outnumbered sellers: 122 funds opened new EW positions and 90 closed out — a net gain of 32 holders — while 463 added to existing stakes and 465 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $348M. The largest seller was Point72 Asset Management, cutting an estimated $224M.

  • 1,295 institutional investors held Edwards Lifesciences (EW) as of Q2 2024, up from 1,279 in Q1 2024.
  • Funds reported $45.6B of Edwards Lifesciences stock for Q2 2024, down 2.2% quarter-over-quarter.
  • 122 funds opened new Edwards Lifesciences positions in Q2 2024 and 90 closed out, a net change of +32 holders.
  • The largest Edwards Lifesciences buyer in Q2 2024 was AllianceBernstein, an estimated $348M added.
  • The largest Edwards Lifesciences seller in Q2 2024 was Point72 Asset Management, an estimated $224M sold.

Based on aggregated 13F filings for Q2 2024.